|
BIOMD0000001041 |
Kimmel2021 - T cell competition and stochastic extinction events in CAR T cell therapy |
4 |
11 |
0 |
1 |
No |
No |
No |
|
BIOMD0000001038 |
Alharbi2019 - Tumor-normal-vitamins model (TNVM) of the effects of vitamins on delaying the growth of tumor cells |
3 |
11 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000001037 |
Alharbi2019 - Tumor-normal model (TNM) of the development of tumor cells and their impact on normal cell dynamics |
2 |
7 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000001036 |
Cappuccio2007 - Tumor-immune system interactions and determination of the optimal therapeutic protocol in immunotherapy |
3 |
14 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000001035 |
Al-Tuwairqi2020 - Dynamics of cancer virotherapy with immune response |
4 |
12 |
1 |
0 |
Yes |
Yes |
No |
|
BIOMD0000001034 |
Bunimovich-Mendrazitsky2007 - Mathematical model of BCG immunotherapy |
4 |
13 |
1 |
0 |
Yes |
Yes |
No |
|
BIOMD0000001033 |
Almuallem2020 - Virus-macrophage-tumour interactions in oncolytic viral therapies |
6 |
32 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000001031 |
Al-Tuwairqi2020 - Dynamics of cancer virotherapy - Phase I treatment |
3 |
5 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000001030 |
Sontag2017 - Dynamic model of immune responses to antigen presentation by tumor or pathogen |
3 |
7 |
0 |
1 |
No |
No |
No |
|
BIOMD0000001025 |
Chaudhury2020 - EC50 expansion and killing mathematical model of CAR-T cell and tumour kinetics |
4 |
15 |
0 |
1 |
No |
No |
No |
|
BIOMD0000001024 |
Chaudhury2020 - Lotka-Volterra mathematical model of CAR-T cell and tumour kinetics |
2 |
5 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000001023 |
Alharbi2020 - An ODE-based model of the dynamics of tumor cell progression and its effects on normal cell growth and immune system functionality |
3 |
17 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000001022 |
Creemers2021 - Tumor-immune dynamics and implications on immunotherapy responses |
4 |
9 |
0 |
0 |
No |
No |
No |
|
BIOMD0000001021 |
Lavigne2021 - Non-spatial model of viral infection dynamics and interferon response of well-mixed viral infection |
7 |
11 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000001018 |
Bakshi2020 - Properdin model of alternative pathway of complement system |
22 |
32 |
5 |
4 |
Yes |
No |
No |
|
BIOMD0000001017 |
Bakshi2020 - Minimal model of alternative pathway of complement system |
13 |
23 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000001016 |
Bakshi2020 - Truncated minimal model of alternative pathway of complement system |
8 |
15 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000001014 |
Leon-Triana2021 - Competition between tumour cells and dual-target CAR T-cells |
5 |
14 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000001013 |
Leon-Triana2021 - Competition between tumour cells and single-target CAR T-cells |
2 |
8 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000001012 |
Leon-Triana2020 - CAR T-cell therapy in B-cell acute lymphoblastic leukaemia with contribution from immature B cells |
4 |
11 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000001011 |
Leon-Triana2020 - CAR T-cell therapy in B-cell acute lymphoblastic leukaemia |
3 |
6 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000001010 |
Zhang2007 - Mechanism of DNA damage response (Model3) |
3 |
28 |
0 |
1 |
No |
No |
No |
|
BIOMD0000001005 |
Bae2017 - Mathematical analysis of circadian disruption and metabolic re-entrainment of hepatic gluconeogenesis |
41 |
136 |
1 |
0 |
No |
No |
No |
|
BIOMD0000001004 |
Intosalmi2015 - Th17 core network model |
10 |
21 |
8 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000001003 |
Strasen2018 - TGFb SMAD Signalling Class 6 |
23 |
51 |
14 |
0 |
No |
No |
No |
|
BIOMD0000001002 |
Strasen2018 - TGFb SMAD Signalling Class 5 |
23 |
50 |
14 |
0 |
No |
No |
No |
|
BIOMD0000001001 |
Strasen2018 - TGFb SMAD Signalling Class 4 |
23 |
51 |
14 |
0 |
No |
No |
No |
|
BIOMD0000001000 |
Strasen2018 - TGFb SMAD Signalling Class 3 |
23 |
51 |
14 |
0 |
No |
No |
No |
|
BIOMD0000000999 |
Strasen2018 - TGFb SMAD Signalling Class 2 |
23 |
51 |
14 |
0 |
No |
No |
No |
|
BIOMD0000000998 |
Strasen2018 - TGFb SMAD Signalling Class 1 |
23 |
50 |
14 |
0 |
No |
No |
No |
|
BIOMD0000000997 |
Strasen2018 - TGFb SMAD Signalling - DRB treatment |
23 |
53 |
14 |
0 |
No |
No |
No |
|
BIOMD0000000991 |
Okuonghae2020 - SEAIR model of COVID-19 transmission in Lagos, Nigeria |
9 |
19 |
0 |
2 |
Yes |
No |
No |
|
BIOMD0000000990 |
Strasen2018 - TGFb SMAD Signalling - Degradation of 25pM ligand (TGFb) |
23 |
50 |
14 |
0 |
No |
No |
No |
|
BIOMD0000000989 |
Strasen2018 - TGFb SMAD Signalling - Dose dependent dynamics upon TGFb stimulation |
23 |
50 |
14 |
0 |
No |
No |
No |
|
BIOMD0000000987 |
Aubry1995 - Nine-compartment model of fluid-phase endocytosis kinetics in Dictyostelium discoideum |
9 |
12 |
0 |
0 |
Yes |
Yes |
Yes |
|
BIOMD0000000985 |
Gex-Fabry1984 - model of receptor-mediated endocytosis of EGF in BALB/c 3T3 cells |
7 |
15 |
1 |
1 |
No |
No |
No |
|
BIOMD0000000984 |
Fang2020 - SEIR model of COVID-19 transmission considering government interventions in Wuhan |
5 |
7 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000982 |
Law2020 - SIR model of COVID-19 transmission in Malyasia with time-varying parameters |
3 |
12 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000980 |
Malkov2020 - SEIRS model of COVID-19 transmission with time-varying R values and reinfection |
5 |
15 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000979 |
Malkov2020 - SEIRS model of COVID-19 transmission with reinfection |
5 |
8 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000977 |
Sarkar2020 - SAIR model of COVID-19 transmission with quarantine measures in India |
6 |
14 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000974 |
Carcione2020 - Deterministic SEIR simulation of a COVID-19 outbreak |
6 |
8 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000972 |
Tang2020 - Estimation of transmission risk of COVID-19 and impact of public health interventions - update |
8 |
23 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000970 |
Hou2020 - SEIR model of COVID-19 transmission in Wuhan |
5 |
9 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000968 |
Palmer2008 - Negative Feedback in IL-7 mediated Jak-Stat signaling |
10 |
15 |
1 |
3 |
Yes |
Yes |
No |
|
BIOMD0000000964 |
Mwalili2020 - SEIR model of COVID-19 transmission and environmental pathogen prevalence |
6 |
17 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000962 |
Zhao2020 - SUQC model of COVID-19 transmission dynamics in Wuhan, Hubei, and China |
5 |
73 |
0 |
2 |
Yes |
Yes |
No |
|
BIOMD0000000958 |
Ndairou2020 - early-stage transmission of dynamics of COVID-19 in Wuhan |
8 |
16 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000957 |
Roda2020 - SIR model of COVID-19 spread in Wuhan |
4 |
5 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000951 |
Mitrophanov2015 - Simulating extended Hockin Blood Coagulation Model under varied pH |
34 |
72 |
9 |
10 |
Yes |
Yes |
Yes |
|
BIOMD0000000950 |
Chitnis2012 - Model Rift Valley Fever transmission between cattle and mosquitoes (Model 1) |
7 |
24 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000949 |
Chitnis2008 - Mathematical model of malaria transmission |
7 |
26 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000948 |
Landberg2009 - Alkylresorcinol Dose Response |
6 |
10 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000947 |
Lee2017 - Paracetamol first-pass metabolism PK model |
9 |
15 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000946 |
Evans2005 - Compartmental model for antineoplastic drug topotecan in breast cancer cells |
7 |
22 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000945 |
Evans2004 - Cell based mathematical model of topotecan |
5 |
16 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000944 |
Goldbeter2013-Oscillatory activity of cyclin-dependent kinases in the cell cycle |
3 |
16 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000942 |
Sible2007 - Mitotic cell cycle mecanism in Xenopus Laevis |
18 |
34 |
0 |
5 |
Yes |
No |
No |
|
BIOMD0000000941 |
Gerard2010 - Progression of mammalian cell cycle by successive activation of various cyclin cdk complexes |
8 |
23 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000940 |
Tang2019 - Pharmacology modelling of AURKB and ZAK interaction in TNBC |
20 |
43 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000939 |
Iwamoto2010 - Cell cycle reponse to DNA damage |
60 |
144 |
6 |
10 |
No |
No |
No |
|
BIOMD0000000938 |
Gerard2013 - Model 3 - Embryonic-type eukaryotic Cell Cycle regulation based on negative feedback between Cdk/cyclin and APC and competitive inhibition between Cdk/cyclin and securin for polyubiquitylation_1 |
5 |
14 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000937 |
Ferrel2011 - Autonomous biochemical oscillator in regulation of CDK1, Plk1, and APC in Xenopus Laevis cell cycle |
3 |
13 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000936 |
ferrel2011 - autonomous biochemical oscillator in cell cycle in Xenopus laevis v2 |
1 |
5 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000935 |
Ferrel2011 - Cdk1 and APC regulation in cell cycle in Xenopus laevis |
2 |
9 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000934 |
Linke2017 - Synchronization of Cyclins' expression by the Fkh2 transcription factor in the budding yeast cell cycle |
16 |
24 |
3 |
3 |
Yes |
Yes |
No |
|
BIOMD0000000933 |
Kosiuk2015-Geometric analysis of the Goldbeter minimal model for the embryonic cell cycle |
3 |
15 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000932 |
Garde2020-Minimal model describing metabolic oscillations in Bacillus subtilis biofilms |
4 |
8 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000930 |
Liu2017 - chemotherapy targeted model of tumor immune system |
4 |
18 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000929 |
Li2016 - Model for pancreatic cancer patients receiving immunotherapy |
5 |
40 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000924 |
Smith2011 - Three Stage Innate Immune Response to a Pneumococcal Lung Infection |
6 |
29 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000922 |
Turner2015-Human/Mosquito ELP Model |
3 |
10 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000921 |
Khajanchi2017 - Uniform Persistence and Global Stability for a Brain Tumor and Immune System Interaction |
5 |
25 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000920 |
Jarrett2015 - Modelling the interaction between immune response, bacterial dynamics and inflammatory damage |
4 |
17 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000919 |
Ledzewicz2013 - On optimal chemotherapy with a strongly targeted agent for a model of tumor immune system interactions with generalized logistic growth |
2 |
10 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000916 |
Kraan199_Kinetics of Cortisol Metabolism and Excretion. |
5 |
7 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000915 |
Sun2018 - Instantaneous mutation rate in cancer initiation and progression |
9 |
32 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000914 |
Parra_Guillen2013 - Mathematical model approach to describe tumour response in mice after vaccine administration_model1 |
5 |
11 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000913 |
dePillis2008 - Optimal control of mixed immunotherapy and chemotherapy of tumors |
6 |
38 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000912 |
Caravagna2010 - Tumour suppression by immune system |
3 |
15 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000911 |
Merola2008 - An insight into tumor dormancy equilibrium via the analysis of its domain of attraction |
3 |
10 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000910 |
Isaeva2008 - Modelling of Anti-Tumour Immune Response Immunocorrective Effect of Weak Centimetre Electromagnetic Waves |
3 |
11 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000909 |
dePillis2003 - The dynamics of an optimally controlled tumor model: A case study |
4 |
18 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000907 |
HeberleRazquinNavas2019 - The PI3K and MAPK/p38 pathways control stress granuleassembly in a hierarchical manner model 3 |
34 |
69 |
0 |
9 |
Yes |
No |
No |
|
BIOMD0000000906 |
Dubey2007 - A mathematical model for the effect of toxicant on the immune system (without toxicant effect) Model1 |
3 |
10 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000905 |
Dubey2007 - A mathematical model for the effect of toxicant on the immune system (with toxicant effect) Model2 |
5 |
16 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000904 |
Admon2017 - Modelling tumor growth with immune response and drug using ordinary differential equations |
4 |
20 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000903 |
Solis-perez2019 - A fractional mathematical model of breast cancer competition model |
5 |
29 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000902 |
Wang2019 - A mathematical model of oncolytic virotherapy with time delay |
4 |
10 |
1 |
0 |
No |
No |
No |
|
BIOMD0000000898 |
Jiao2018 - Feedback regulation in a stem cell model with acute myeloid leukaemia |
5 |
23 |
3 |
0 |
Yes |
No |
No |
|
BIOMD0000000897 |
Khajanchi2015 - The combined effects of optimal control in cancer remission |
2 |
11 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000896 |
Szymanska2009 - Mathematical modeling of heat shock protein synthesis in response to temperature change |
9 |
21 |
3 |
2 |
No |
No |
No |
|
BIOMD0000000895 |
Schokker2013 - A mathematical model representing cellular immune development and response to Salmonella of chicken intestinal tissue |
9 |
50 |
4 |
0 |
No |
No |
No |
|
BIOMD0000000894 |
Bose2011 - Noise-assisted interactions of tumor and immune cells |
3 |
9 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000893 |
GonzalezMiranda2013 - The effect of circadian oscillations on biochemical cell signaling by NF-κB |
3 |
7 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000892 |
Sandip2013 - Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin. |
4 |
12 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000891 |
Khajanchi2019 - Stability Analysis of a Mathematical Model forGlioma-Immune Interaction under OptimalTherapy |
3 |
13 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000890 |
Bhattacharya2014 - A mathematical model of the sterol regulatory element binding protein 2 cholesterol biosynthesis pathway |
3 |
12 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000889 |
Fribourg2014 - Model of influenza A virus infection dynamics of viral antagonism and innate immune response. |
12 |
51 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000888 |
Unni2019 - Mathematical Modeling, Analysis, and Simulation of Tumor Dynamics with Drug Interventions |
4 |
22 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000887 |
Lim2014 - HTLV-I infection A dynamic struggle between viral persistence and host immunity |
4 |
11 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000886 |
Dubey2008 - Modeling the interaction between avascular cancerous cells and acquired immune response |
5 |
19 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000885 |
Sumana2018 - Mathematical modeling of cancer-immune system, considering the role of antibodies. |
4 |
12 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000884 |
Cortes2019 - Optimality of the spontaneous prophage induction rate. |
3 |
10 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000883 |
Giani2019 - Computational modeling to predict MAP3K8 effects as mediator of resistance to vemurafenib in thyroid cancer stem cells |
75 |
169 |
1 |
22 |
No |
No |
No |
|
BIOMD0000000882 |
Munz2009 - Zombie SIZRC |
3 |
6 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000881 |
Kogan2013 - A mathematical model for the immunotherapeutic control of the TH1 TH2 imbalance in melanoma |
4 |
28 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000880 |
Trisilowati2018 - Optimal control of tumor-immune system interaction with treatment |
4 |
15 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000879 |
Rodrigues2019 - A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia |
3 |
19 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000878 |
Lenbury2001_InsulinKineticsModel_A |
3 |
14 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000877 |
Ontah2019 - Dynamic analysis of a tumor treatment model using oncolytic virus and chemotherapy with saturated infection rate |
4 |
13 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000876 |
Aavani2019 - The role of CD4 T cells in immune system activation and viral reproduction in a simple model for HIV infection |
4 |
12 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000875 |
Nelson2000- HIV-1 general model 1 |
4 |
9 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000874 |
Perelson1993 - HIVinfection_CD4Tcells_ModelA |
4 |
11 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000871 |
NIK-dependent p100 processing into p52 with RelB binding and IkBd degradation, mass action, SBML 2v4 |
8 |
22 |
4 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000870 |
Simon2019 - NIK-dependent p100 processing into p52 and IkBd degradation, mass action, SBML 2v4 |
7 |
17 |
3 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000869 |
Simon2019 - NIK-dependent p100 processing into p52 and IkBd degradation, Michaelis-Menten, SBML 2v4 |
5 |
14 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000868 |
Simon2019 - NIK-dependent p100 processing into p52, Mass Action, SBML 2v4 |
5 |
10 |
1 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000867 |
Coulibaly2019 - Interleukin-15 Signaling in HIF-1a Regulation in Natural Killer Cells |
10 |
58 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000866 |
Simon2019 - NIK-dependent p100 processing into p52, Michaelis-Menten, SBML 2v4 |
4 |
8 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000863 |
Kosinsky2018 - Radiation and PD-(L)1 treatment combinations |
6 |
28 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000861 |
Bachmann2011 - Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range |
26 |
38 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000859 |
Larbat2016.3 - Modeling the diversion of primary carbon flux into secondary metabolism under variable nitrate and light or dark conditions (Light Dark Cycles with Minimum Starch Adaption) |
13 |
48 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000858 |
Larbat2016.2 - Modeling the diversion of primary carbon flux into secondary metabolism under variable nitrate and light or dark conditions (Light Dark Cycles) |
10 |
38 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000857 |
Larbat2016.1 - Modeling the diversion of primary carbon flux into secondary metabolism under variable nitrate and light or dark conditions (Base Model) |
10 |
36 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000855 |
Cooper2015 - Modeling the effects of systemic mediators on the inflammatory phase of wound healing |
4 |
40 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000854 |
Gray2016 - The Akt switch model |
4 |
11 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000853 |
Smolen2018 - Paradoxical LTP maintenance with inhibition of protein synthesis and the proteasome |
9 |
33 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000852 |
Andersen2017 - Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development |
6 |
36 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000851 |
Ho2019 - Mathematical models of transmission dynamics and vaccine strategies in Hong Kong during the 2017-2018 winter influenza season (Simple) |
5 |
19 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000850 |
Jenner2019 - Oncolytic virotherapy for tumours following a Gompertz growth law |
3 |
5 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000848 |
FatehiChenar2018 - Mathematical model of immune response to hepatitis B |
9 |
29 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000847 |
Adams2019 - The regulatory role of shikimate in plant phenylalanine metabolism |
4 |
18 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000842 |
Heitzler2012 - GPCR signalling |
21 |
43 |
9 |
8 |
Yes |
Yes |
No |
|
BIOMD0000000841 |
Dhawan2019 - Endogenous miRNA sponges mediate the generation of oscillatory dynamics for a non-coding RNA network |
4 |
16 |
2 |
0 |
No |
No |
No |
|
BIOMD0000000840 |
Caldwell2019 - The Vicodin abuse problem |
5 |
11 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000839 |
Almeida2019 - Transcription-based circadian mechanism controls the duration of molecular clock states in response to signaling inputs |
8 |
30 |
2 |
0 |
Yes |
No |
No |
|
BIOMD0000000838 |
Tsur2019 - Response of patients with melanoma to immune checkpoint blockade |
3 |
9 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000837 |
Hanson2016 - Toxicity Management in CAR T cell therapy for B-ALL |
8 |
23 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000836 |
Radosavljevic2009_BioterroristAttack_PanicProtection_1 |
2 |
6 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000835 |
Rao2014 - Fatty acid beta-oxidation (reduced model) |
55 |
226 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000833 |
DiCamillo2016 - Insulin signalling pathway - Rule-based model |
61 |
242 |
2 |
19 |
Yes |
No |
No |
|
BIOMD0000000832 |
Shin2016 - Unveiling Hidden Dynamics of Hippo Signalling |
20 |
69 |
2 |
7 |
Yes |
No |
No |
|
BIOMD0000000831 |
Smith1980 - Hypothalamic Regulation |
3 |
10 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000827 |
Ito2019 - gefitnib resistance of lung adenocarcinoma caused by MET amplification |
10 |
18 |
2 |
3 |
Yes |
Yes |
No |
|
BIOMD0000000826 |
Shin_2018_EGFR-PYK2-c-Met interaction network_model |
13 |
90 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000824 |
Lewkiewics2019 - effects of aging on naive T cell populations and diversity |
2 |
8 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000823 |
Varusai2018 - Dynamic modelling of the mTOR signalling network reveals complex emergent behaviours conferred by DEPTOR |
16 |
44 |
0 |
5 |
Yes |
No |
No |
|
BIOMD0000000821 |
Yazdjer2019 - reinforcement learning-based control of tumor growth under anti-angiogenic therapy |
3 |
9 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000815 |
Chrobak2011 - A mathematical model of induced cancer-adaptive immune system competition |
2 |
7 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000813 |
Anderson2015 - Qualitative behavior of systems of tumor-CD4+-cytokine interactions with treatments |
3 |
13 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000812 |
Galante2012 - B7-H1 and a Mathematical Model for Cytotoxic T Cell and Tumor Cell Interaction |
6 |
17 |
1 |
2 |
Yes |
No |
No |
|
BIOMD0000000811 |
He2017 - A mathematical model of pancreatic cancer with two kinds of treatments |
6 |
53 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000810 |
Ganguli2018-immuno regulatory mechanisms in tumor microenvironment |
14 |
71 |
2 |
1 |
No |
No |
No |
|
BIOMD0000000808 |
Kronik2008 - Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics |
6 |
41 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000807 |
Fassoni2019 - Oncogenesis encompassing mutations and genetic instability |
3 |
29 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000802 |
Hoffman2018- ADCC against cancer |
4 |
12 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000801 |
Sturrock2015 - glioma growth |
4 |
18 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000800 |
Precup2012 - Mathematical modeling of cell dynamics after allogeneic bone marrow transplantation |
3 |
11 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000799 |
Cucuianu2010 - A hypothetical-mathematical model of acute myeloid leukaemia pathogenesis |
2 |
7 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000798 |
Sharp2019 - AML |
5 |
15 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000797 |
Hu2018 - Dynamics of tumor-CD4+-cytokine-host cells interactions with treatments |
4 |
20 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000796 |
Yang2012 - cancer growth with angiogenesis |
5 |
28 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000795 |
Chen2011/2 - bone marrow invasion relative model |
2 |
7 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000793 |
Chen2011/1 - bone marrow invasion absolute model |
2 |
5 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000792 |
Hu2019 - Modeling Pancreatic Cancer Dynamics with Immunotherapy |
6 |
29 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000790 |
Alvarez2019 - A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity |
4 |
19 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000788 |
Schropp2019 - Target-Mediated Drug Disposition Model for Bispecific Antibodies |
8 |
23 |
6 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000785 |
Sotolongo-Costa2003 - Behavior of tumors under nonstationary therapy |
2 |
4 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000783 |
Dong2014 - Mathematical modeling on helper t cells in a tumor immune system |
3 |
9 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000782 |
Wang2016/3 - oncolytic efficacy of M1 virus-SN model |
2 |
7 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000781 |
Wang2016/2 - oncolytic efficacy of M1 virus-SNT model |
3 |
11 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000780 |
Wang2016/1 - oncolytic efficacy of M1 virus-SNTM model |
4 |
16 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000779 |
dePillis2009 - Mathematical model creation for cancer chemo-immunotherapy |
6 |
45 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000778 |
Wei2017 - tumor, T cell and cytokine interaction |
3 |
15 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000777 |
Chakrabarty2010 - A control theory approach to cancer remission aided by an optimal therapy |
3 |
10 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000776 |
Monro2008 - chemotherapy resistance |
2 |
8 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000774 |
Wodarz2018/1 - simple model |
2 |
14 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000773 |
Wodarz2018/2 - model with transit amplifying cells |
3 |
22 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000772 |
Wang2019 - A mathematical model of oncolytic virotherapy with time delay |
4 |
10 |
1 |
0 |
No |
No |
No |
|
BIOMD0000000771 |
Bajzer2008 - Modeling of cancer virotherapy with recombinant measles viruses |
3 |
9 |
1 |
0 |
No |
No |
No |
|
BIOMD0000000770 |
Eftimie2017/1 - interaction of Th and macrophage |
4 |
17 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000769 |
Eftimie2017/2 - interaction of Th and macrophage in melanoma |
5 |
28 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000768 |
Eftimie2010 - immunity to melanoma |
5 |
24 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000767 |
Macnamara2015/2 - virotherapy virus-free submodel |
3 |
9 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000766 |
Macnamara2015/1 - virotherapy full model |
5 |
16 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000765 |
Mager2005 - Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition |
4 |
15 |
1 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000764 |
Malinzi2019 - chemovirotherapy |
4 |
26 |
1 |
0 |
No |
No |
No |
|
BIOMD0000000763 |
Dritschel2018 - A mathematical model of cytotoxic and helper T cell interactions in a tumour microenvironment |
3 |
9 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000762 |
Kuznetsov1994 - Nonlinear dynamics of immunogenic tumors |
2 |
9 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000761 |
Cappuccio2006 - Cancer immunotherapy by interleukin-21 |
6 |
23 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000760 |
Feizabadi2011/1 - immunodeficiency in cancer core model |
2 |
10 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000759 |
den Breems2015 - macrophage in cancer |
6 |
25 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000758 |
Babbs2012 - immunotherapy |
2 |
5 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000757 |
Abernathy2016 - glioblastoma treatment |
10 |
33 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000756 |
Figueredo2013/3 - immunointeraction full model |
4 |
21 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000755 |
Hansen2019 - Nine species reduced model of blood coagulation |
9 |
11 |
1 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000754 |
Figueredo2013/2 - immunointeraction model with IL2 |
3 |
14 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000753 |
Figueredo2013/1 - immunointeraction base model |
2 |
9 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000752 |
Wilkie2013r - immune-induced cancer dormancy and immune evasion-resistance |
3 |
10 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000751 |
Wilkie2013b - immune-induced cancer dormancy and immune evasion-basic |
2 |
7 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000750 |
Lolas2016 - tumour-induced neoneurogenesis and perineural tumour growth |
8 |
42 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000748 |
Phan2017 - innate immune in oncolytic virotherapy |
4 |
9 |
1 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000747 |
Nagashima2002 - Simulating blood coagulation inhibitory effects |
33 |
54 |
4 |
9 |
Yes |
Yes |
Yes |
|
BIOMD0000000746 |
Saad2017 - immune checkpoint and BCG in superficial bladder cancer |
4 |
13 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000745 |
Jarrett2018 - trastuzumab-induced immune response in murine HER2+ breast cancer model |
5 |
14 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000744 |
Hu2019 - Pancreatic cancer dynamics |
5 |
24 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000743 |
Gallaher2018 - Tumor–Immune dynamics in multiple myeloma |
4 |
32 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000742 |
Garcia2018basic - cancer and immune cell count basic model |
2 |
7 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000741 |
Eftimie2018 - Cancer and Immune biomarkers |
4 |
29 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000740 |
Panteleev2010 - Blood Coagulation: Full Model |
43 |
68 |
0 |
11 |
Yes |
No |
No |
|
BIOMD0000000738 |
Mouse Iron Distribution - Rich iron diet (No Tracer) |
12 |
41 |
8 |
1 |
Yes |
No |
No |
|
BIOMD0000000737 |
Mouse Iron Distribution - Deficient iron diet (No Tracer) |
12 |
41 |
8 |
1 |
Yes |
No |
No |
|
BIOMD0000000733 |
Moore_2004_Mathematical model for CML and T cell interaction |
3 |
13 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000732 |
Kirschner1998_Immunotherapy_Tumour |
5 |
17 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000730 |
Gerard2009 - An Integrated Mammalian Cell Cycle Model |
45 |
188 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000729 |
Goldbeter1996 - Cyclin Cdc2 kinase Oscillations |
3 |
16 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000728 |
Norel1990 - MPF and Cyclin Oscillations |
2 |
5 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000726 |
Ruan2017 - Transmission dynamics and control of rabies in China |
8 |
18 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000725 |
Salcedo-Sora2016 - Microbial folate biosynthesis and utilisation |
51 |
107 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000724 |
Theinmozhi2018 - Mechanism of PD1 inhibiting TCR signaling in Tumor immune regulation |
39 |
62 |
2 |
21 |
Yes |
No |
No |
|
BIOMD0000000722 |
Bianchi2015 -Model for lymphangiogenesis in normal and diabetic wounds |
5 |
34 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000721 |
Graham2013 - Role of osteocytes in targeted bone remodeling |
5 |
26 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000720 |
Yan2012 - Rb-E2F pathway dynamics with miR449 |
9 |
31 |
5 |
0 |
Yes |
No |
No |
|
BIOMD0000000717 |
Lee2018 - Avian human half-saturated incidence (HSI) model |
4 |
22 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000716 |
Lee2018 - Avian human bilinear incidence (BI) model |
4 |
22 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000715 |
Huo2017 - SEIS epidemic model with the impact of media |
5 |
12 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000714 |
Reynolds2006 - Reduced model of the acute inflammatory response |
4 |
26 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000713 |
Aston2018 - Dynamics of Hepatitis C Infection |
3 |
9 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000710 |
Hernandez-Vargas2012 - Innate immune system dynamics to Influenza virus |
7 |
18 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000709 |
Liu2017 - Dynamics of Avian Influenza with Allee Growth Effect |
5 |
14 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000708 |
Liu2017 - Dynamics of Avian Influenza with Logistic Growth |
5 |
14 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000707 |
Revilla2003 - Controlling HIV infection using recombinant viruses |
5 |
11 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000705 |
Smith2010 - Response of FOXO Transcription Factors to Post-Translational Modifications Made by Ageing-Related Signalling Pathways |
43 |
26 |
0 |
9 |
Yes |
Yes |
No |
|
BIOMD0000000704 |
Aguda1999 - G2 DNA damage checkpoint |
17 |
42 |
2 |
2 |
Yes |
No |
No |
|
BIOMD0000000700 |
Heldt2018 - Proliferation-quiescence decision in response to DNA damage |
30 |
59 |
14 |
9 |
No |
No |
No |
|
BIOMD0000000698 |
Reed2004 - Methionine Cycle |
7 |
25 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000697 |
Ciliberto2003 - CyclinE / Cdk2 timer in the cell cycle of Xenopus laevis embryo |
16 |
27 |
3 |
2 |
No |
No |
No |
|
BIOMD0000000692 |
Phillips2003 - The Mechanism of Ras GTPase Activation by Neurofibromin |
8 |
16 |
0 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000691 |
Wolf2000 - Cellular interaction on glycolytic oscillations in yeast |
19 |
19 |
2 |
4 |
Yes |
No |
No |
|
BIOMD0000000690 |
Thiaville2016 - Folate pathway model (PanB overexpression and THF regulation) |
17 |
24 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000689 |
Thiaville2016 - Folate pathway model (PanB overexpression) |
17 |
24 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000688 |
Wodarz2007 - Cytomegalovirus infection model with cytotoxic T lymphocyte and natural killer cell response |
16 |
21 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000687 |
Wodarz2007 - Cytomegalovirus infection model with cytotoxic T lymphocyte response |
15 |
17 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000683 |
Wodarz1999 CTL memory response HIV |
4 |
13 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000680 |
Waugh2006 - Diabetic Wound Healing - TGF-B Dynamics |
4 |
12 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000679 |
Waugh2006 - Diabetic Wound Healing - Macrophage Dynamics |
4 |
12 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000678 |
Tomida2003 - Calcium Oscillatory-induced translocation of nuclear factor of activated T cells |
4 |
12 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000676 |
Chen2006 - Nitric Oxide Release from Endothelial Cells |
15 |
25 |
2 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000671 |
Murphy2016 - Differences in predictions of ODE models of tumor growth |
7 |
15 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000670 |
Owen1998 - tumour growth model |
3 |
9 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000668 |
Zhu2015 - Combined gemcitabine and birinapant in pancreatic cancer cells - basic PD model |
14 |
27 |
0 |
4 |
Yes |
Yes |
No |
|
BIOMD0000000667 |
Hornberg2005 - MAPKsignalling |
103 |
91 |
47 |
7 |
Yes |
Yes |
No |
|
BIOMD0000000666 |
Pappalardo2016 - PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer |
48 |
116 |
0 |
15 |
Yes |
No |
No |
|
BIOMD0000000665 |
Fallon2000 - Interleukin-2 dynamics |
8 |
14 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000664 |
Muller2008 - Simplified MAPK activation Dynamics (Model B) |
8 |
21 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000663 |
Wodarz2007 - HIV/CD4 T-cell interaction |
3 |
8 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000662 |
Moore2004 - Chronic Myeloid Leukemic cells and T-lymphocyte interaction |
5 |
15 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000661 |
Webb2002 - Fas/FasL mediated tumor T-cell interaction |
7 |
14 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000660 |
Barr2017 - Dynamics of p21 in hTert-RPE1 cells |
20 |
34 |
10 |
3 |
No |
No |
No |
|
BIOMD0000000658 |
Lee2003 - Roles of APC and Axin in Wnt Pathway (without regulatory loop) |
16 |
37 |
1 |
5 |
No |
No |
No |
|
BIOMD0000000657 |
Araujo2016 - Positive feedback in Cdk1 signalling keeps mitotic duration short and constant |
3 |
22 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000656 |
Padala2017- ERK, PI3K/Akt and Wnt signalling network (EGFR overexpression) |
54 |
118 |
25 |
15 |
No |
No |
No |
|
BIOMD0000000655 |
Padala2017- ERK, PI3K/Akt and Wnt signalling network (PTEN mutation) |
54 |
117 |
24 |
14 |
No |
No |
No |
|
BIOMD0000000654 |
Padala2017- ERK, PI3K/Akt and Wnt signalling network (Ras mutated) |
54 |
117 |
24 |
14 |
No |
No |
No |
|
BIOMD0000000653 |
Padala2017- ERK, PI3K/Akt and Wnt signalling network (bRaf mutated) |
54 |
115 |
23 |
14 |
No |
No |
No |
|
BIOMD0000000652 |
Padala2017- ERK, PI3K/Akt and Wnt signalling network (PI3K mutated) |
54 |
118 |
25 |
14 |
No |
No |
No |
|
BIOMD0000000651 |
Nguyen2016 - Feedback regulation in cell signalling: Lessons for cancer therapeutics |
29 |
48 |
0 |
13 |
Yes |
Yes |
No |
|
BIOMD0000000648 |
Padala2017- ERK, PI3K/Akt and Wnt signalling network (normal) |
54 |
119 |
25 |
14 |
No |
No |
No |
|
BIOMD0000000647 |
Kwang2003 - The influence of RKIP on the ERK signaling pathway |
11 |
17 |
1 |
5 |
Yes |
Yes |
Yes |
|
BIOMD0000000646 |
Barr2016 - All-or-nothing G1/S transition |
18 |
28 |
4 |
8 |
Yes |
Yes |
No |
|
BIOMD0000000642 |
Mufudza2012 - Estrogen effect on the dynamics of breast cancer |
4 |
20 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000641 |
Jaiswal2017 - Cell cycle arrest |
12 |
13 |
0 |
4 |
Yes |
No |
No |
|
BIOMD0000000640 |
DallePezze2016 - Activation of AMPK and mTOR by amino acids |
45 |
72 |
0 |
25 |
No |
No |
No |
|
BIOMD0000000639 |
Thiaville2016 - Wild type folate pathway model with proposed PanB reaction |
17 |
24 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000638 |
Bush2016 - Extended Carrousel model of GPCR-RGS |
21 |
68 |
23 |
4 |
Yes |
Yes |
Yes |
|
BIOMD0000000637 |
Bush2016 - Simplified Carrousel model of GPCR |
12 |
56 |
9 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000631 |
DeCaluwe2016 - Circadian Clock |
12 |
48 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000630 |
Venkatraman2011 - PLS-UPA behaviour in the presence of substrate competition_1_1_1_1 |
6 |
15 |
4 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000629 |
Haffez2017 - RAR interaction with synthetic analogues |
5 |
8 |
0 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000626 |
Ray2013 - Meiotic initiation in S. cerevisiae |
6 |
21 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000625 |
Leber2016 - Expanded model of Tfh-Tfr differentiation - Helicobacter pylori infection |
19 |
53 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000624 |
Sluka2016 - Acetaminophen metabolism |
7 |
12 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000623 |
Orton2009 - Modelling cancerous mutations in the EGFR/ERK pathway - EGF Model |
31 |
72 |
0 |
11 |
Yes |
No |
No |
|
BIOMD0000000622 |
NguyenLK2011 - Ubiquitination dynamics in Ring1B/Bmi1 system |
11 |
27 |
1 |
1 |
Yes |
No |
No |
|
BIOMD0000000616 |
Dunster2014 - WBC Interactions (Model1) |
4 |
9 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000615 |
Kuznetsov2016(II) - α-syn aggregation kinetics in Parkinson's Disease |
4 |
13 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000614 |
Kamihira2000 |
1 |
4 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000609 |
Reddyhoff2015 - Acetaminophen metabolism and toxicity |
5 |
12 |
2 |
0 |
Yes |
Yes |
Yes |
|
BIOMD0000000608 |
Palsson2013 - Fully-integrated immune response model (FIRM) |
52 |
279 |
64 |
0 |
Yes |
No |
No |
|
BIOMD0000000602 |
Stavrum2013 - Tryptophan Metabolism in Liver |
56 |
148 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000600 |
Cellière2011 - Plasticity of TGF-β Signalling |
18 |
29 |
3 |
3 |
No |
No |
No |
|
BIOMD0000000599 |
Coggins2014 - CXCL12 dependent recruitment of beta arrestin |
30 |
44 |
10 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000594 |
Capuani2015 - Binding of Cbl and Gbr2 to EGFR (Multisite Phosphorylation Model - MPM) |
33 |
36 |
21 |
7 |
Yes |
Yes |
No |
|
BIOMD0000000590 |
Hermansen2015 - denovo biosynthesis of pyrimidines in yeast |
9 |
31 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000588 |
Benson2013 - Identification of key drug targets in nerve growth factor pathway |
76 |
261 |
65 |
14 |
Yes |
No |
No |
|
BIOMD0000000585 |
Rateitschak2012 - Interferon-gamma (IFNγ) induced STAT1 signalling (PC_IFNg100) |
28 |
23 |
0 |
8 |
Yes |
No |
No |
|
BIOMD0000000583 |
Leber2015 - Mucosal immunity and gut microbiome interaction during C. difficile infection |
23 |
60 |
1 |
1 |
Yes |
No |
No |
|
BIOMD0000000582 |
DallePezze2014 - Cellular senescene-induced mitochondrial dysfunction |
40 |
61 |
0 |
22 |
No |
No |
No |
|
BIOMD0000000581 |
DallePezze2012 - TSC-independent mTORC2 regulation |
28 |
47 |
15 |
10 |
Yes |
Yes |
Yes |
|
BIOMD0000000580 |
Sonntag2012 - mTOR model - IRS dependent regulation of AMPK by insulin |
39 |
50 |
0 |
25 |
No |
No |
No |
|
BIOMD0000000576 |
Kolodkin2013 - Nuclear receptor-mediated cortisol signalling network |
42 |
78 |
5 |
7 |
Yes |
No |
No |
|
BIOMD0000000573 |
Aguilera 2014 - HIV latency. Interaction between HIV proteins and immune response |
2 |
9 |
2 |
0 |
Yes |
No |
No |
|
BIOMD0000000572 |
Costa2014 - Computational Model of L. lactis Metabolism |
26 |
125 |
1 |
7 |
Yes |
No |
No |
|
BIOMD0000000567 |
Morris2009 - α-Synuclein aggregation variable temperature and pH |
2 |
6 |
1 |
1 |
No |
No |
No |
|
BIOMD0000000565 |
Machado2014 - Curcumin production pathway in Escherichia coli |
26 |
152 |
10 |
0 |
No |
No |
No |
|
BIOMD0000000561 |
Martins2013 - True and apparent inhibition of amyloid fribril formation |
1 |
9 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000560 |
Hui2016 - Age-related changes in articular cartilage |
65 |
132 |
44 |
11 |
Yes |
No |
No |
|
BIOMD0000000559 |
Ouzounoglou2014 - Modeling of alpha-synuclein effects on neuronal homeostasis |
90 |
29 |
26 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000000558 |
Cloutier2012 - Feedback motif for Parkinson's disease |
2 |
9 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000557 |
Reiterer2013 - pseudophosphatase STYX role in ERK signalling |
25 |
56 |
4 |
9 |
No |
No |
No |
|
BIOMD0000000553 |
Ehrenstein1997 - The choline-leakage hypothesis in Alzheimer's disease |
3 |
5 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000552 |
Ehrenstein2000 - Positive-Feedback model for the loss of acetylcholine in Alzheimer's disease |
3 |
5 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000550 |
Baker2013 - Cytokine Mediated Inflammation in Rheumatoid Arthritis |
2 |
6 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000549 |
Baker2013 - Cytokine Mediated Inflammation in Rheumatoid Arthritis - Age Dependent |
2 |
9 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000548 |
Sneppen2009 - Modeling proteasome dynamics in Parkinson's disease |
3 |
5 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000545 |
Ouyang2014 - photomorphogenic UV-B signalling network |
14 |
29 |
1 |
3 |
Yes |
No |
No |
|
BIOMD0000000544 |
Qi2013 - IL-6 and IFN crosstalk model |
108 |
222 |
29 |
20 |
Yes |
No |
No |
|
BIOMD0000000543 |
Qi2013 - IL-6 and IFN crosstalk model (non-competitive) |
111 |
237 |
34 |
20 |
Yes |
No |
No |
|
BIOMD0000000539 |
François2005 - Mixed Feedback Loop (two-gene network) |
6 |
13 |
1 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000538 |
Clarke2000 - One-hit model of cell death in neuronal degenerations |
3 |
6 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000533 |
Steckmann2012 - Amyloid beta-protein fibrillogenesis (kinetics of secondary structure conversion) |
11 |
8 |
0 |
2 |
Yes |
Yes |
No |
|
BIOMD0000000530 |
Schmitz2014 - RNA triplex formation |
10 |
18 |
3 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000526 |
Kallenberger2014 - CD95L induced apoptosis initiated by caspase-8, wild-type HeLa cells (cis/trans-cis/trans variant) |
18 |
23 |
0 |
7 |
Yes |
No |
No |
|
BIOMD0000000525 |
Kallenberger2014 - CD95L induced apoptosis initiated by caspase-8, CD95 HeLa cells (cis/trans-cis/trans variant) |
18 |
23 |
0 |
7 |
Yes |
No |
No |
|
BIOMD0000000524 |
Kallenberger2014 - CD95L induced apoptosis initiated by caspase-8, wild-type HeLa cells (cis/trans variant) |
18 |
20 |
0 |
7 |
Yes |
No |
No |
|
BIOMD0000000523 |
Kallenberger2014 - CD95L induced apoptosis initiated by caspase-8, CD95 HeLa cells (cis/trans variant) |
18 |
20 |
0 |
7 |
Yes |
No |
No |
|
BIOMD0000000522 |
Muraro2014 - Vascular patterning in Arabidopsis roots |
16 |
70 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000521 |
Ribba2012 - Low-grade gliomas, tumour growth inhibition model |
4 |
12 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000520 |
Smallbone2013 - Colon Crypt cycle - Version 0 |
3 |
13 |
4 |
0 |
Yes |
No |
No |
|
BIOMD0000000519 |
Smallbone2013 - Colon Crypt cycle - Version 1 |
3 |
14 |
4 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000518 |
Smallbone2013 - Colon Crypt cycle - Version 2 |
4 |
21 |
5 |
0 |
Yes |
No |
No |
|
BIOMD0000000517 |
Smallbone2013 - Colon Crypt cycle - Version 3 |
4 |
21 |
5 |
0 |
Yes |
No |
No |
|
BIOMD0000000516 |
Kerkhoven2013 - Glycolysis and Pentose Phosphate Pathway in T.brucei - MODEL D in fructose medium (with ATP:ADP antiporter) |
50 |
200 |
2 |
7 |
No |
No |
No |
|
BIOMD0000000515 |
Kerkhoven2013 - Glycolysis and Pentose Phosphate Pathway in T.brucei - MODEL C in fructose medium (with glucosomal ribokinase) |
51 |
203 |
2 |
8 |
No |
No |
No |
|
BIOMD0000000514 |
Kerkhoven2013 - Glycolysis and Pentose Phosphate Pathway in T.brucei - MODEL B |
46 |
169 |
2 |
7 |
No |
No |
No |
|
BIOMD0000000513 |
Kerkhoven2013 - Glycolysis in T.brucei - MODEL A |
31 |
105 |
0 |
5 |
No |
No |
No |
|
BIOMD0000000512 |
Benson2014 - FAAH inhibitors for the treatment of osteoarthritic pain |
39 |
160 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000511 |
Kerkhoven2013 - Glycolysis and Pentose Phosphate Pathway in T.brucei - MODEL D (with ATP:ADP antiporter) |
46 |
173 |
2 |
7 |
No |
No |
No |
|
BIOMD0000000510 |
Kerkhoven2013 - Glycolysis and Pentose Phosphate Pathway in T.brucei - MODEL C (with glucosomal ribokinase) |
47 |
176 |
2 |
8 |
No |
No |
No |
|
BIOMD0000000507 |
Gardner2000 - genetic toggle switch in E.coli |
3 |
12 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000506 |
vanEunen2013 - Network dynamics of fatty acid β-oxidation (time-course model) |
54 |
233 |
6 |
2 |
No |
No |
No |
|
BIOMD0000000505 |
vanEunen2013 - Network dynamics of fatty acid β-oxidation (steady-state model) |
54 |
234 |
6 |
1 |
Yes |
No |
No |
|
BIOMD0000000504 |
Proctor2013 - Cartilage breakdown, interventions to reduce collagen release |
75 |
152 |
50 |
13 |
Yes |
Yes |
No |
|
BIOMD0000000502 |
Messiha2013 - Pentose phosphate pathway model |
21 |
64 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000501 |
Begitt2014 - STAT1 cooperative DNA binding - double GAS polymer model |
35 |
10 |
11 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000000500 |
Begitt2014 - STAT1 cooperative DNA binding - single GAS polymer model |
14 |
11 |
4 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000000499 |
Vizan2013 - TGF pathway long term signaling |
26 |
30 |
0 |
12 |
Yes |
No |
No |
|
BIOMD0000000498 |
Mitchell2013 - Liver Iron Metabolism |
21 |
72 |
5 |
0 |
Yes |
No |
No |
|
BIOMD0000000492 |
Pathak2013 - MAPK activation in response to various biotic stresses |
52 |
182 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000491 |
Pathak2013 - MAPK activation in response to various abiotic stresses |
57 |
178 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000489 |
Sharp2013 - Lipopolysaccharide induced NFkB activation |
53 |
110 |
20 |
4 |
Yes |
No |
No |
|
BIOMD0000000487 |
Cao2013 - Application of ABSIS in the the enzymatic futile cycle |
6 |
10 |
1 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000486 |
Cao2013 - Application of ABSIS method in the reversible isomerization model |
2 |
4 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000485 |
Cao2013 - Application of ABSIS method in the bistable Schlögl model |
2 |
10 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000484 |
Cao2013 - Application of ABSIS method in birth-death process |
2 |
4 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000483 |
Cao2008 - Network of a toggle switch |
8 |
13 |
0 |
4 |
Yes |
Yes |
No |
|
BIOMD0000000482 |
Noguchi2013 - Insulin dependent glucose metabolism |
23 |
65 |
7 |
5 |
Yes |
No |
No |
|
BIOMD0000000478 |
Besozzi2012 - Oscillatory regimes in the Ras/cAMP/PKA pathway in S.cerevisiae |
33 |
51 |
7 |
8 |
Yes |
Yes |
No |
|
BIOMD0000000477 |
Mol2013 - Immune Signal Transduction in Leishmaniasis |
43 |
86 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000476 |
Adams2012 - Locke2006 Circadian Rhythm model refined with Input Signal Light Function |
16 |
84 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000475 |
Amara2013 - PCNA ubiquitylation in the activation of PRR pathway |
23 |
34 |
2 |
7 |
Yes |
Yes |
Yes |
|
BIOMD0000000474 |
Smith2013 - Regulation of Insulin Signalling by Oxidative Stress |
133 |
412 |
7 |
37 |
No |
No |
No |
|
BIOMD0000000468 |
Koo2013 - Integrated shear stress induced NO production model |
79 |
165 |
6 |
23 |
No |
No |
No |
|
BIOMD0000000467 |
Koo2013 - Shear stress induced NO production - Model 4 |
20 |
24 |
5 |
3 |
Yes |
No |
No |
|
BIOMD0000000466 |
Koo2013 - Shear stress induced eNOS expression - Model 3 |
34 |
77 |
1 |
13 |
No |
No |
No |
|
BIOMD0000000465 |
Koo2013 - Shear stress induced AKT and eNOS phosphorylation - Model 2 |
16 |
30 |
0 |
5 |
No |
No |
No |
|
BIOMD0000000464 |
Koo2013 - Shear stress induced calcium influx and eNOS activation - Model 1 |
14 |
36 |
0 |
3 |
No |
No |
No |
|
BIOMD0000000463 |
Heldt2012 - Influenza Virus Replication |
39 |
58 |
17 |
6 |
Yes |
No |
No |
|
BIOMD0000000462 |
Proctor2012 - Role of Amyloid-beta dimers in aggregation formation |
6 |
12 |
2 |
0 |
Yes |
No |
No |
|
BIOMD0000000461 |
Liebal2012 - B.subtilis transcription inhibition model |
4 |
8 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000460 |
Liebal2012 - B.subtilis sigB proteolysis model |
4 |
9 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000459 |
Liebal2012 - B.subtilis post-transcriptional instability model |
4 |
9 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000458 |
Smallbone2013 - Serine biosynthesis |
7 |
16 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000457 |
Firczuk2013 - Eukaryotic mRNA translation machinery |
166 |
86 |
0 |
22 |
Yes |
No |
No |
|
BIOMD0000000456 |
Smallbone2013 - Metabolic Control Analysis - Example 3 |
11 |
21 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000455 |
Smallbone2013 - Metabolic Control Analysis - Example 2 |
9 |
17 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000454 |
Smallbone2013 - Metabolic Control Analysis - Example 1 |
8 |
15 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000453 |
Bidkhori2012 - EGFR signalling in NSCLC |
109 |
210 |
30 |
22 |
Yes |
No |
No |
|
BIOMD0000000452 |
Bidkhori2012 - normal EGFR signalling |
109 |
209 |
30 |
22 |
Yes |
No |
No |
|
BIOMD0000000451 |
Carbo2013 - Cytokine driven CD4+ T Cell differentiation and phenotype plasticity |
94 |
230 |
0 |
12 |
No |
No |
No |
|
BIOMD0000000449 |
Brännmark2013 - Insulin signalling in human adipocytes (diabetic condition) |
27 |
79 |
0 |
10 |
No |
No |
No |
|
BIOMD0000000448 |
Brännmark2013 - Insulin signalling in human adipocytes (normal condition) |
27 |
79 |
0 |
10 |
No |
No |
No |
|
BIOMD0000000447 |
Venkatraman2012 - Interplay between PLS and TSP1 in TGF-β1 activation |
13 |
24 |
11 |
0 |
Yes |
Yes |
Yes |
|
BIOMD0000000446 |
Erguler2013 - Unfolded protein stress response |
27 |
98 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000444 |
Sarma2012 - Oscillations in MAPK cascade (S2n) |
18 |
51 |
0 |
3 |
No |
No |
No |
|
BIOMD0000000443 |
Sarma2012 - Oscillations in MAPK cascade (S1n) |
19 |
51 |
0 |
3 |
No |
No |
No |
|
BIOMD0000000442 |
Sarma2012 - Oscillations in MAPK cascade (S2), inclusion of external signalling module |
13 |
35 |
0 |
4 |
Yes |
No |
No |
|
BIOMD0000000441 |
Sarma2012 - Oscillations in MAPK cascade (S2) |
11 |
28 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000440 |
Sarma2012 - Oscillations in MAPK cascade (S1) |
11 |
29 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000435 |
deBack2012 - Lineage Specification in Pancreas Development |
4 |
19 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000434 |
McAuley2012 - Whole-body Cholesterol Metabolism |
34 |
57 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000433 |
Sarma2012 - Interaction topologies of MAPK cascade (M4_K2_QSS_PSEQ) |
11 |
31 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000432 |
Sarma2012 - Interaction topologies of MAPK cascade (M4_K2_QSS_USEQ) |
11 |
31 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000431 |
Sarma2012 - Interaction topologies of MAPK cascade (M4_K2_PSEQ) |
27 |
52 |
7 |
6 |
Yes |
Yes |
Yes |
|
BIOMD0000000430 |
Sarma2012 - Interaction topologies of MAPK cascade (M4_K2_USEQ) |
27 |
52 |
7 |
6 |
Yes |
Yes |
Yes |
|
BIOMD0000000428 |
Achcar2012 - Glycolysis in bloodstream form T. brucei |
31 |
97 |
0 |
5 |
No |
No |
No |
|
BIOMD0000000427 |
Bianconi2012 - EGFR and IGF1R pathway in lung cancer |
21 |
63 |
12 |
8 |
Yes |
No |
No |
|
BIOMD0000000426 |
Mosca2012 - Central Carbon Metabolism Regulated by AKT |
34 |
197 |
1 |
3 |
No |
No |
No |
|
BIOMD0000000425 |
Tan2012 - Antibiotic Treatment, Inoculum Effect |
1 |
7 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000424 |
Faratian2009 - Role of PTEN in Trastuzumab resistance |
55 |
127 |
9 |
12 |
Yes |
No |
No |
|
BIOMD0000000423 |
Nyman2012_InsulinSignalling |
9 |
23 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000416 |
Muraro2011_Cytokinin-Auxin_CrossRegulation |
32 |
51 |
0 |
12 |
Yes |
No |
No |
|
BIOMD0000000415 |
Mellor2012_LipooxygenasePathway |
10 |
18 |
0 |
8 |
Yes |
No |
No |
|
BIOMD0000000414 |
Band2012_DII-Venus_ReducedModel |
1 |
5 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000413 |
Band2012_DII-Venus_FullModel |
5 |
12 |
1 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000411 |
Heiland2012_CircadianClock_C.reinhardtii |
10 |
39 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000410 |
Wegner2012_TGFbetaSignalling_FeedbackLoops |
53 |
154 |
21 |
1 |
Yes |
No |
No |
|
BIOMD0000000409 |
Queralt2006_MitoticExit_Cdc55DownregulationBySeparase |
24 |
57 |
0 |
9 |
Yes |
No |
No |
|
BIOMD0000000407 |
Schliemann2011_TNF_ProAntiApoptosis |
47 |
109 |
17 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000406 |
Moriya2011_CellCycle_FissionYeast |
49 |
144 |
7 |
0 |
No |
No |
No |
|
BIOMD0000000405 |
Cookson2011_EnzymaticQueueingCoupling |
6 |
7 |
2 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000400 |
Cooling2007_IP3transients_CardiacMyocyte |
13 |
56 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000399 |
Jenkinson2011_EGF_MAPK |
100 |
107 |
41 |
18 |
No |
No |
No |
|
BIOMD0000000397 |
Sivakumar2011_WntSignalingPathway |
50 |
92 |
0 |
27 |
Yes |
No |
No |
|
BIOMD0000000396 |
Sivakumar2011 - Notch Signaling Pathway |
36 |
87 |
0 |
17 |
Yes |
No |
No |
|
BIOMD0000000391 |
Arnold2011_Poolman2000_CalvinCycle_Starch |
22 |
81 |
1 |
2 |
Yes |
No |
No |
|
BIOMD0000000390 |
Arnold2011_Giersch1990_CalvinCycle |
11 |
26 |
0 |
3 |
No |
No |
No |
|
BIOMD0000000389 |
Arnold2011_Hahn1986_CalvinCycle_Starch_Sucrose |
22 |
31 |
1 |
4 |
Yes |
Yes |
No |
|
BIOMD0000000388 |
Arnold2011_Zhu2009_CalvinCycle |
8 |
19 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000384 |
Arnold2011_Medlyn2002_RuBisCO-CalvinCycle |
6 |
18 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000383 |
Arnold2011_Farquhar1980_RuBisCO-CalvinCycle |
6 |
15 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000370 |
Vinod2011_MitoticExit |
32 |
106 |
0 |
7 |
Yes |
No |
No |
|
BIOMD0000000369 |
Beltrami1995_ThrombinGeneration_D |
7 |
11 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000368 |
Beltrami1995_ThrombinGeneration_C |
8 |
11 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000366 |
Orfao2008_ThrombinGeneration_AmidolyticActivity |
12 |
19 |
0 |
4 |
Yes |
No |
No |
|
BIOMD0000000365 |
Hockin1999_BloodCoagulation_VaInactivation |
30 |
15 |
4 |
5 |
Yes |
Yes |
Yes |
|
BIOMD0000000364 |
Lee2010_ThrombinActivation_OneForm |
14 |
24 |
2 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000363 |
Lee2010_ThrombinActivation_OneForm_minimal |
4 |
6 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000362 |
Butenas2004_BloodCoagulation |
34 |
56 |
9 |
10 |
Yes |
Yes |
Yes |
|
BIOMD0000000361 |
Panteleev2002_TFPImechanism_schmema1 |
8 |
13 |
0 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000360 |
Panteleev2002_TFPImechanism_schmema2 |
9 |
19 |
1 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000359 |
Panteleev2002_TFPImechanism_schmema3 |
9 |
19 |
2 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000358 |
Stortelder1997 - Thrombin Generation Amidolytic Activity |
12 |
19 |
0 |
4 |
Yes |
No |
No |
|
BIOMD0000000357 |
Lee2010_ThrombinActivation_OneForm_reduced |
9 |
15 |
0 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000000355 |
Abell2011_CalciumSignaling_WithAdaptation |
9 |
26 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000354 |
Abell2011_CalciumSignaling_WithoutAdaptation |
6 |
24 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000353 |
Nag2011_ChloroplasticStarchDegradation |
28 |
77 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000350 |
Troein2011_ClockCircuit_OstreococcusTauri |
14 |
30 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000347 |
Bachmann2011_JAK2-STAT5_FeedbackControl |
26 |
38 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000346 |
FitzHugh1961_NerveMembrane |
2 |
5 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000341 |
Topp2000_BetaCellMass_Diabetes |
3 |
10 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000335 |
Hockin2002_BloodCoagulation |
34 |
54 |
7 |
10 |
Yes |
Yes |
Yes |
|
BIOMD0000000334 |
Bungay2003_Thrombin_Generation |
74 |
125 |
7 |
14 |
Yes |
Yes |
No |
|
BIOMD0000000333 |
Bungay2006_FollicularFluid |
54 |
88 |
3 |
12 |
Yes |
Yes |
No |
|
BIOMD0000000332 |
Bungay2006_Plasma |
78 |
129 |
7 |
15 |
Yes |
Yes |
No |
|
BIOMD0000000329 |
Kummer2000 - Oscillations in Calcium Signalling |
3 |
13 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000328 |
Bucher2011_Atorvastatin_Metabolism |
18 |
35 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000325 |
Palini2011_Minimal_2_Feedback_Model |
6 |
17 |
2 |
0 |
Yes |
No |
No |
|
BIOMD0000000323 |
Kim2011_Oscillator_SimpleIII |
3 |
7 |
3 |
0 |
Yes |
No |
No |
|
BIOMD0000000322 |
Kim2011_Oscillator_SimpleI |
4 |
15 |
4 |
0 |
No |
No |
No |
|
BIOMD0000000321 |
Grange2001 - L Dopa PK model |
3 |
21 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000320 |
Grange2001 - PK interaction of L-dopa and benserazide |
9 |
38 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000319 |
Decroly1982_Enzymatic_Oscillator |
3 |
8 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000315 |
Montagne2011_Oligator_optimised |
20 |
52 |
10 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000314 |
Raia2011 - IL13 L1236 |
12 |
15 |
0 |
3 |
Yes |
Yes |
No |
|
BIOMD0000000313 |
Raia2010 - IL13 Signalling MedB1 |
16 |
22 |
0 |
4 |
Yes |
No |
No |
|
BIOMD0000000312 |
Tyson2003_Perfect_Adaption |
3 |
6 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000311 |
Tyson2003_Mutual_Activation |
4 |
10 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000310 |
Tyson2003_Mutual_Inhibition |
4 |
13 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000309 |
Tyson2003_NegFB_Homeostasis |
4 |
11 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000308 |
Tyson2003_NegFB_Oscillator |
6 |
16 |
0 |
2 |
Yes |
No |
No |
|
BIOMD0000000307 |
Tyson2003_Substrate_Depletion_Osc |
5 |
13 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000306 |
Tyson2003_Activator_Inhibitor |
5 |
15 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000303 |
Liu2011_Complement_System |
42 |
102 |
2 |
11 |
Yes |
No |
No |
|
BIOMD0000000300 |
Schmierer2010_FIH_Ankyrins |
16 |
21 |
0 |
9 |
No |
No |
No |
|
BIOMD0000000299 |
Leloup1999_CircadianRhythms_Neurospora |
3 |
13 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000298 |
Leloup1999_CircadianRhythms_Drosophila |
10 |
40 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000296 |
Balagaddé2008_E_coli_Predator_Prey |
7 |
15 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000295 |
Akman2008_Circadian_Clock_Model1 |
5 |
19 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000294 |
Restif2007 - Vaccination invasion |
11 |
23 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000292 |
Rovers1995_Photsynthetic_Oscillations |
6 |
8 |
1 |
2 |
Yes |
Yes |
No |
|
BIOMD0000000291 |
Nikolaev2005_AlbuminBilirubinAdsorption |
10 |
14 |
0 |
3 |
Yes |
Yes |
No |
|
BIOMD0000000290 |
Alexander2010_Tcell_Regulation_Sys2 |
5 |
18 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000289 |
Alexander2010_Tcell_Regulation_Sys1 |
5 |
17 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000288 |
Wang2009 - PI3K Ras Crosstalk |
19 |
46 |
0 |
6 |
No |
No |
No |
|
BIOMD0000000286 |
Proctor2010 - a link between GSK3 and p53 in Alzheimer's Disease |
59 |
70 |
43 |
7 |
No |
No |
No |
|
BIOMD0000000284 |
Hofmeyer1986_SeqFb_Proc_AA_Synthesis |
9 |
4 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000283 |
Chance1943_Peroxidase_ES_Kinetics |
4 |
5 |
0 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000000282 |
Chance1952_Catalase_Mechanism |
6 |
8 |
0 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000000278 |
Lemaire2004 - Role of RANK/RANKL/OPG pathway in bone remodelling process |
3 |
31 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000275 |
Goldbeter2007_Somitogenesis_Switch |
5 |
25 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000274 |
Rattanakul2003_BoneFormationModel |
3 |
14 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000272 |
Becker2010_EpoR_AuxiliaryModel |
6 |
15 |
1 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000271 |
Becker2010_EpoR_CoreModel |
6 |
16 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000270 |
Schilling2009 - ERK distributive |
33 |
49 |
0 |
9 |
Yes |
Yes |
No |
|
BIOMD0000000269 |
Liu2010_Hormonal_Crosstalk_Arabidopsis |
18 |
40 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000268 |
Reed2008_Glutathione_Metabolism |
44 |
173 |
9 |
4 |
No |
No |
No |
|
BIOMD0000000267 |
Lebeda2008 - BoNT paralysis (3 step model) |
4 |
10 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000264 |
Fujita2010_Akt_Signalling_EGFRinhib |
14 |
31 |
3 |
3 |
No |
No |
No |
|
BIOMD0000000263 |
Fujita2010_Akt_Signalling_NGF |
11 |
28 |
2 |
3 |
No |
No |
No |
|
BIOMD0000000262 |
Fujita2010_Akt_Signalling_EGF |
11 |
28 |
2 |
3 |
No |
No |
No |
|
BIOMD0000000261 |
Tiago2010_FeMetabolism_FeLoaded |
17 |
33 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000260 |
Tiago2010_FeMetabolism_FeAdequate |
17 |
33 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000259 |
Tiago2010_FeMetabolism_FeDeficient |
17 |
33 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000258 |
Ortega2006 - bistability from double phosphorylation in signal transduction |
3 |
11 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000257 |
Piedrafita2010_MR_System |
11 |
23 |
0 |
0 |
Yes |
Yes |
Yes |
|
BIOMD0000000254 |
Bier2000_GlycolyticOscillation |
4 |
8 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000253 |
Teusink1998_Glycolysis_TurboDesign |
6 |
28 |
0 |
2 |
Yes |
No |
No |
|
BIOMD0000000252 |
Hunziker2010_p53_StressSpecificResponse |
4 |
10 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000251 |
Nakakuki2010_CellFateDecision_Core |
10 |
21 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000250 |
Nakakuki2010_CellFateDecision_Mechanistic |
49 |
158 |
4 |
10 |
No |
No |
No |
|
BIOMD0000000249 |
Restif2006 - Whooping cough |
9 |
22 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000247 |
Ralser2007_Carbohydrate_Rerouting_ROS |
31 |
146 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000243 |
Neumann2010_CD95Stimulation_NFkB_Apoptosis |
23 |
19 |
3 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000242 |
Bai2003_G1phaseRegulation |
6 |
27 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000240 |
Veening2008_DegU_Regulation |
6 |
24 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000239 |
Jiang2007 - GSIS system, Pancreatic Beta Cells |
59 |
326 |
3 |
15 |
No |
No |
No |
|
BIOMD0000000237 |
Schaber2006_Pheromone_Starvation_Crosstalk |
26 |
53 |
3 |
4 |
No |
No |
No |
|
BIOMD0000000236 |
Westermark2003_Pancreatic_GlycOsc_extended |
7 |
28 |
0 |
3 |
No |
No |
No |
|
BIOMD0000000233 |
Wilhelm2009_BistableReaction |
4 |
7 |
1 |
0 |
Yes |
Yes |
Yes |
|
BIOMD0000000231 |
Valero2006_Adenine_TernaryCycle |
6 |
12 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000230 |
Ihekwaba2004_NFkB_Sensitivity |
26 |
68 |
18 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000229 |
Ma2002_cAMP_oscillations |
7 |
15 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000228 |
Swat2004_Mammalian_G1_S_Transition |
9 |
41 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000226 |
Radulescu2008_NFkB_hierarchy_M_14_25_28_Lipniacky |
24 |
45 |
4 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000225 |
Westermark2003_Pancreatic_GlycOsc_basic |
5 |
22 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000224 |
Meyer1991_CalciumSpike_ICC |
4 |
15 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000222 |
Singh2006_TCA_Ecoli_glucose |
12 |
54 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000221 |
Singh2006_TCA_Ecoli_acetate |
12 |
54 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000220 |
Albeck2008_extrinsic_apoptosis |
58 |
100 |
2 |
18 |
Yes |
Yes |
No |
|
BIOMD0000000219 |
Singh2006_TCA_mtu_model1 |
13 |
75 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000218 |
Singh2006_TCA_mtu_model2 |
13 |
71 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000217 |
Bruggeman2005_AmmoniumAssimilation |
22 |
112 |
2 |
3 |
No |
No |
No |
|
BIOMD0000000216 |
Hong2009_CircadianClock |
6 |
20 |
2 |
2 |
Yes |
No |
No |
|
BIOMD0000000215 |
Schulz2009_Th1_differentiation |
7 |
21 |
0 |
1 |
No |
No |
No |
|
BIOMD0000000214 |
Akman2008_Circadian_Clock_Model2 |
16 |
40 |
0 |
4 |
No |
No |
No |
|
BIOMD0000000213 |
Nijhout2004_Folate_Cycle |
14 |
48 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000212 |
Curien2009_Aspartate_Metabolism |
31 |
88 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000211 |
Albert2005_Glycolysis |
27 |
92 |
0 |
5 |
No |
No |
No |
|
BIOMD0000000210 |
Chickarmane2008 - Stem cell lineage - NANOG GATA-6 switch |
18 |
57 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000209 |
Chickarmane2008 - Stem cell lineage determination |
20 |
62 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000208 |
Deineko2003_CellCycle |
6 |
19 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000206 |
Wolf2000_Glycolytic_Oscillations |
9 |
19 |
2 |
0 |
Yes |
No |
No |
|
BIOMD0000000205 |
Ung2008_EGFR_Endocytosis |
194 |
351 |
47 |
37 |
Yes |
Yes |
Yes |
|
BIOMD0000000204 |
Chickarmane2006 - Stem cell switch irreversible |
12 |
40 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000203 |
Chickarmane2006 - Stem cell switch reversible |
12 |
40 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000201 |
Goldbeter2008_Somite_Segmentation_Clock_Notch_Wnt_FGF |
26 |
72 |
0 |
4 |
Yes |
No |
No |
|
BIOMD0000000200 |
Bray1995_chemotaxis_receptorlinkedcomplex |
22 |
54 |
18 |
5 |
Yes |
Yes |
Yes |
|
BIOMD0000000199 |
Santolini2001_nNOS_Mechanism_Regulation |
15 |
18 |
0 |
2 |
Yes |
Yes |
No |
|
BIOMD0000000198 |
Stone1996 - activation of soluble guanylate cyclase by nitric oxide |
12 |
20 |
0 |
4 |
Yes |
Yes |
No |
|
BIOMD0000000192 |
Görlich2003_RanGTP_gradient |
13 |
24 |
1 |
3 |
Yes |
No |
No |
|
BIOMD0000000191 |
Montañez2008_Arginine_catabolism |
3 |
21 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000185 |
Locke2008_Circadian_Clock |
8 |
20 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000184 |
Lavrentovich2008_Ca_Oscillations |
3 |
16 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000182 |
Neves2008 - Role of cell shape and size in controlling intracellular signalling |
37 |
102 |
2 |
13 |
Yes |
No |
No |
|
BIOMD0000000181 |
Sriram2007_CellCycle |
6 |
26 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000178 |
Lebeda2008 - BoTN Paralysis (4 step model) |
6 |
11 |
0 |
2 |
Yes |
Yes |
No |
|
BIOMD0000000177 |
Conant2007_glycolysis_2C |
28 |
111 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000176 |
Conant2007_WGD_glycolysis_2A3AB |
25 |
109 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000174 |
Del_Conte_Zerial2008_Rab5_Rab7_cut_out_switch |
4 |
19 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000173 |
Schmierer_2008_Smad_Tgfb |
26 |
28 |
7 |
5 |
No |
No |
No |
|
BIOMD0000000172 |
Pritchard2002_glycolysis |
25 |
99 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000171 |
Leloup1998_CircClock_LD |
12 |
43 |
1 |
2 |
No |
No |
No |
|
BIOMD0000000170 |
Weimann2004_CircadianOscillator |
7 |
29 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000169 |
Aguda1999_CellCycle |
11 |
33 |
2 |
0 |
Yes |
No |
No |
|
BIOMD0000000167 |
Mayya2005_STATmodule |
9 |
19 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000166 |
Zhu2007_TF_modulated_by_Calcium |
3 |
24 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000165 |
Saucerman2006_PKA |
37 |
78 |
4 |
12 |
No |
No |
No |
|
BIOMD0000000164 |
SmithAE2002_RanTransport |
26 |
76 |
8 |
4 |
No |
No |
No |
|
BIOMD0000000163 |
Zi2007_TGFbeta_signaling |
16 |
27 |
2 |
2 |
Yes |
Yes |
No |
|
BIOMD0000000162 |
Hernjak2005_Calcium_Signaling |
32 |
215 |
8 |
0 |
No |
No |
No |
|
BIOMD0000000161 |
Eungdamrong2007_Ras_Activation |
46 |
165 |
0 |
13 |
No |
No |
No |
|
BIOMD0000000159 |
Zatorsky2006_p53_Model1 |
3 |
8 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000157 |
Zatorsky2006_p53_Model4 |
3 |
9 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000156 |
Zatorsky2006_p53_Model5 |
3 |
8 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000154 |
Zatorsky2006_p53_Model3 |
2 |
8 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000151 |
Singh2006_IL6_Signal_Transduction |
68 |
124 |
16 |
14 |
Yes |
No |
No |
|
BIOMD0000000147 |
ODea2007_IkappaB |
24 |
77 |
18 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000146 |
Hatakeyama2003_MAPK |
36 |
87 |
2 |
11 |
Yes |
No |
No |
|
BIOMD0000000145 |
Wang2007 - ATP induced intracellular Calcium Oscillation |
7 |
34 |
0 |
2 |
Yes |
No |
No |
|
BIOMD0000000143 |
Olsen2003_neutrophil_oscillatory_metabolism |
20 |
29 |
1 |
2 |
Yes |
No |
No |
|
BIOMD0000000123 |
Fisher2006_NFAT_Activation |
14 |
30 |
3 |
3 |
Yes |
Yes |
No |
|
BIOMD0000000116 |
McClean2007_CrossTalk |
6 |
21 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000115 |
Somogyi1990_CaOscillations_SingleCaSpike |
2 |
11 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000114 |
Somogyi1990_CaOscillations |
2 |
11 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000113 |
Dupont1992_Ca_dpt_protein_phospho |
4 |
21 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000112 |
Clarke2006_Smad_signalling |
10 |
23 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000110 |
Qu2003_CellCycle |
15 |
31 |
1 |
2 |
Yes |
No |
No |
|
BIOMD0000000108 |
Kowald2006_SOD |
9 |
19 |
8 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000107 |
Novak1993 - Cell cycle M-phase control |
14 |
37 |
0 |
5 |
Yes |
No |
No |
|
BIOMD0000000106 |
Yang2007_ArachidonicAcid |
25 |
55 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000105 |
Proctor2007 - Age related decline of proteolysis, ubiquitin-proteome system |
39 |
26 |
63 |
4 |
Yes |
Yes |
No |
|
BIOMD0000000103 |
Legewie2006_apoptosis_NC |
17 |
50 |
24 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000102 |
Legewie2006_apoptosis_WT |
13 |
42 |
15 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000100 |
Rozi2003_GlycogenPhosphorylase_Activation |
5 |
34 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000099 |
Laub1998_SpontaneousOscillations |
7 |
16 |
0 |
0 |
Yes |
Yes |
No |
|
BIOMD0000000098 |
Goldbeter1990_CalciumSpike_CICR |
2 |
15 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000093 |
Yamada2003_JAK_STAT_pathway |
34 |
82 |
17 |
6 |
Yes |
No |
No |
|
BIOMD0000000092 |
Fuentes2005_ZymogenActivation |
4 |
7 |
1 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000000091 |
Proctor2005 - Actions of chaperones and their role in ageing |
16 |
26 |
4 |
3 |
Yes |
Yes |
No |
|
BIOMD0000000090 |
Wolf2001_Respiratory_Oscillations |
26 |
40 |
2 |
4 |
Yes |
No |
No |
|
BIOMD0000000089 |
Locke2006_CircClock_LL |
16 |
79 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000086 |
Bornheimer2004_GTPaseCycle |
17 |
56 |
12 |
5 |
Yes |
Yes |
Yes |
|
BIOMD0000000085 |
Maurya2005_GTPaseCycle_reducedOrder |
17 |
42 |
5 |
5 |
Yes |
Yes |
Yes |
|
BIOMD0000000084 |
Hornberg2005_ERKcascade |
8 |
23 |
0 |
4 |
Yes |
No |
No |
|
BIOMD0000000083 |
Leloup2003_CircClock_LD_REV-ERBalpha |
19 |
65 |
2 |
0 |
No |
No |
No |
|
BIOMD0000000082 |
Thomsen1988_AdenylateCyclase_Inhibition |
10 |
17 |
0 |
6 |
Yes |
Yes |
Yes |
|
BIOMD0000000080 |
Thomsen1989_AdenylateCyclase |
10 |
17 |
0 |
6 |
Yes |
Yes |
Yes |
|
BIOMD0000000079 |
Goldbeter2006_weightCycling |
3 |
12 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000078 |
Leloup2003_CircClock_LD |
16 |
82 |
2 |
0 |
No |
No |
No |
|
BIOMD0000000076 |
Cronwright2002_Glycerol_Synthesis |
3 |
21 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000075 |
Xu2003 - Phosphoinositide turnover |
13 |
42 |
1 |
3 |
No |
No |
No |
|
BIOMD0000000074 |
Leloup2003_CircClock_DD_REV-ERBalpha |
19 |
96 |
2 |
0 |
Yes |
No |
No |
|
BIOMD0000000073 |
Leloup2003_CircClock_DD |
16 |
81 |
2 |
0 |
Yes |
No |
No |
|
BIOMD0000000072 |
Yi2003_GproteinCycle |
7 |
11 |
1 |
2 |
Yes |
Yes |
No |
|
BIOMD0000000070 |
Holzhutter2004_Erythrocyte_Metabolism |
45 |
179 |
1 |
7 |
Yes |
No |
No |
|
BIOMD0000000069 |
Fuss2006_MitoticActivation |
10 |
25 |
0 |
4 |
Yes |
Yes |
No |
|
BIOMD0000000068 |
Curien2003_MetThr_synthesis |
9 |
12 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000067 |
Fung2005_Metabolic_Oscillator |
8 |
23 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000066 |
Chassagnole2001_Threonine Synthesis |
11 |
52 |
0 |
4 |
No |
No |
No |
|
BIOMD0000000065 |
Yildirim2003_Lac_Operon |
9 |
25 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000064 |
Teusink2000_Glycolysis |
26 |
95 |
0 |
4 |
No |
No |
No |
|
BIOMD0000000062 |
Bhartiya2003_Tryptophan_operon |
4 |
19 |
0 |
2 |
No |
No |
No |
|
BIOMD0000000061 |
Hynne2001_Glycolysis |
25 |
76 |
1 |
2 |
Yes |
No |
No |
|
BIOMD0000000060 |
Keizer1996_Ryanodine_receptor_adaptation |
4 |
13 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000058 |
Bindschadler2001_coupled_Ca_oscillators |
4 |
30 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000057 |
Sneyd2002_IP3_Receptor |
6 |
35 |
0 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000055 |
Locke2005 - Circadian Clock |
13 |
68 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000054 |
Ataullahkhanov1996_Adenylate |
3 |
11 |
1 |
0 |
No |
No |
No |
|
BIOMD0000000053 |
Ferreira2003_CML_generation2 |
6 |
32 |
2 |
0 |
No |
No |
No |
|
BIOMD0000000052 |
Brands2002 - Monosaccharide-casein systems |
11 |
13 |
1 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000050 |
Martins2003_AmadoriDegradation |
14 |
18 |
4 |
1 |
Yes |
Yes |
Yes |
|
BIOMD0000000049 |
Sasagawa2005_MAPK |
99 |
257 |
55 |
16 |
Yes |
No |
No |
|
BIOMD0000000048 |
Kholodenko1999 - EGFR signaling |
23 |
57 |
7 |
6 |
Yes |
No |
No |
|
BIOMD0000000046 |
Olsen2003_peroxidase |
16 |
22 |
2 |
2 |
Yes |
Yes |
No |
|
BIOMD0000000045 |
Borghans1997 - Calcium Oscillation - Model 3 |
4 |
23 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000044 |
Borghans1997 - Calcium Oscillation - Model 2 |
4 |
23 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000043 |
Borghans1997 - Calcium Oscillation - Model 1 |
5 |
20 |
0 |
2 |
Yes |
No |
No |
|
BIOMD0000000042 |
Nielsen1998_Glycolysis |
15 |
26 |
8 |
0 |
Yes |
No |
No |
|
BIOMD0000000041 |
Kongas2007 - Creatine Kinase in energy metabolic signaling in muscle |
10 |
33 |
2 |
3 |
Yes |
No |
No |
|
BIOMD0000000040 |
Field1974_Oregonator |
5 |
9 |
1 |
0 |
Yes |
Yes |
Yes |
|
BIOMD0000000039 |
Marhl2000_CaOscillations |
5 |
18 |
0 |
2 |
Yes |
No |
No |
|
BIOMD0000000038 |
Rohwer2000_Phosphotransferase_System |
17 |
29 |
0 |
4 |
Yes |
Yes |
Yes |
|
BIOMD0000000037 |
Marwan2003 - Genetics, regulatory hierarchy between genes |
12 |
17 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000036 |
Tyson1999_CircClock |
3 |
14 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000035 |
Vilar2002_Oscillator |
10 |
20 |
6 |
2 |
Yes |
Yes |
Yes |
|
BIOMD0000000033 |
Brown2004 - NGF and EGF signaling |
32 |
64 |
0 |
15 |
Yes |
No |
No |
|
BIOMD0000000032 |
Kofahl2004_PheromonePathway |
37 |
62 |
5 |
11 |
Yes |
No |
No |
|
BIOMD0000000031 |
Markevich2004_MAPK_orderedMM2kinases |
6 |
11 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000030 |
Markevich2004_MAPK_AllRandomElementary |
18 |
36 |
3 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000029 |
Markevich2004_MAPK_phosphoRandomMM |
6 |
17 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000028 |
Markevich2004_MAPK_phosphoRandomElementary |
16 |
31 |
3 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000027 |
Markevich2004 - MAPK double phosphorylation, ordered Michaelis-Menton |
5 |
11 |
0 |
1 |
Yes |
No |
No |
|
BIOMD0000000026 |
Markevich2004_MAPK_orderedElementary |
11 |
20 |
2 |
3 |
Yes |
Yes |
Yes |
|
BIOMD0000000024 |
Scheper1999_CircClock |
3 |
10 |
0 |
0 |
No |
No |
No |
|
BIOMD0000000023 |
Rohwer2001_Sucrose |
13 |
63 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000022 |
Ueda2001_CircClock |
13 |
72 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000021 |
Leloup1999_CircClock |
10 |
50 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000019 |
Schoeberl2002 - EGF MAPK |
100 |
107 |
41 |
18 |
No |
No |
No |
|
BIOMD0000000017 |
Hoefnagel2002_PyruvateBranches |
19 |
83 |
0 |
3 |
No |
No |
No |
|
BIOMD0000000015 |
Curto1998 - purine metabolism |
18 |
114 |
3 |
0 |
No |
No |
No |
|
BIOMD0000000014 |
Levchenko2000_MAPK_Scaffold |
86 |
309 |
92 |
8 |
Yes |
Yes |
Yes |
|
BIOMD0000000013 |
Poolman2004_CalvinCycle |
27 |
90 |
1 |
2 |
Yes |
No |
No |
|
BIOMD0000000011 |
Levchenko2000_MAPK_noScaffold |
22 |
38 |
5 |
7 |
Yes |
Yes |
Yes |
|
BIOMD0000000010 |
Kholodenko2000 - Ultrasensitivity and negative feedback bring oscillations in MAPK cascade |
8 |
26 |
0 |
3 |
Yes |
No |
No |
|
BIOMD0000000009 |
Huang1996 - Ultrasensitivity in MAPK cascade |
26 |
39 |
5 |
11 |
Yes |
No |
No |
|
BIOMD0000000008 |
Gardner1998 - Cell Cycle Goldbeter |
5 |
24 |
1 |
0 |
Yes |
No |
No |
|
BIOMD0000000006 |
Tyson1991 - Cell Cycle 2 var |
4 |
7 |
0 |
1 |
Yes |
Yes |
No |
|
BIOMD0000000004 |
Goldbeter1991 - Min Mit Oscil, Expl Inact |
5 |
18 |
0 |
2 |
Yes |
No |
No |
|
BIOMD0000000003 |
Goldbeter1991 - Min Mit Oscil |
3 |
16 |
0 |
0 |
Yes |
No |
No |
|
BIOMD0000000002 |
Edelstein1996 - EPSP ACh species |
13 |
37 |
6 |
2 |
Yes |
Yes |
Yes |